IGF1R and chordoma: Both the primary and recurrent chordoma of the trial patient contained patchy IGF-1R signal that was weaker in the primary biopsy and one of the blocks (C, psoas deposit) of recurrent tumor and stronger and more uniformly positive in two further blocks (A, B; deposits in connective tissue) from the 2008 (pre-trial) recurrence (Figure 3B).